Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurosci Res ; 90(5): 945-54, 2012 May.
Article in English | MEDLINE | ID: mdl-22497022

ABSTRACT

To survive, cells must rapidly repair (seal) plasmalemmal damage. Cytosolic oxidation has been shown to increase cell survival in some cases and produce cell death in other protocols. An antioxidant (melatonin; Mel) has been reported to decrease the probability of sealing plasmalemmal damage. Here we report that plasmalemmal damage produces cytosolic oxidation, as assayed by methylene blue (MB) color change in rat B104 hippocampal cells. Plasmalemmal sealing is affected by duration of Ca²âº deprivation and length of exposure to, and concentration of, oxidizing agents such as H2O2 and thimerosal (TH). Cytosolic oxidation by 10 µM to 50 mM H2O2 or 100 µM to 2 mM TH increases the probability of Ca²âº-dependent plasmalemmal sealing, whereas higher concentrations of H2O2 decrease sealing probability and also damage uninjured cells. We also show that antioxidants (Mel, MB) or reducing agents (dithiothreitol) decrease sealing. Proteins, such as protein kinase A, SNAP-25, synaptobrevin, and N-ethylmaleimide-sensitive factor (previously reported to enhance sealing in other pathways), also enhance sealing in this oxidation pathway. In brief, our data show that plasmalemmal damage produces cytosolic oxidation that increases the probability of plasmalemmal sealing, which is strongly correlated with cell survival in other studies. Our results may provide new insights into the etiology and treatment of oxidation-dependent neurodegenerative disorders, such as Parkinson's, Huntington's, and Alzheimer's diseases.


Subject(s)
Axotomy , Cell Membrane/physiology , Cytosol/physiology , Neurites/metabolism , Wound Healing/physiology , Animals , Antioxidants/pharmacology , Calcium/metabolism , Cell Line, Tumor , Cell Membrane/drug effects , Cytosol/drug effects , Dose-Response Relationship, Drug , Drug Interactions , Hydrogen Peroxide/pharmacology , Neurites/drug effects , Neuroblastoma/pathology , Oxidants/pharmacology , Oxidation-Reduction/drug effects , Protein Kinase Inhibitors/pharmacology , Rats , Time Factors , Wound Healing/drug effects
2.
J Neurosci Res ; 90(5): 967-80, 2012 May.
Article in English | MEDLINE | ID: mdl-22302646

ABSTRACT

Behavioral function lost in mammals (including humans) after peripheral nerve severance is slowly (weeks to years) and often poorly restored by 1-2-mm/day, nonspecifically directed outgrowths from proximal axonal stumps. To survive, proximal stumps must quickly repair (seal) plasmalemmal damage. We report that, after complete cut- or crush-severance of rat sciatic nerves, morphological continuity, action potential conduction, and behavioral functions can be consistently (>98% of trials), rapidly (minutes to days), dramatically (70-85% recovery), and chronically restored and some Wallerian degeneration prevented. We assess axoplasmic and axolemmal continuity by intra-axonal dye diffusion and action potential conduction across the lesion site and amount of behavioral recovery by Sciatic Functional Index and Foot Fault tests. We apply well-specified sequences of solutions containing FDA-approved chemicals. First, severed axonal ends are opened and resealing is prevented by hypotonic Ca²âº-free saline containing antioxidants (especially methylene blue) that inhibit plasmalemmal sealing in sciatic nerves in vivo, ex vivo, and in rat B104 hippocampal cells in vitro. Second, a hypotonic solution of polyethylene glycol (PEG) is applied to open closely apposed (by microsutures, if cut) axonal ends to induce their membranes to flow rapidly into each other (PEG-fusion), consistent with data showing that PEG rapidly seals (PEG-seals) transected neurites of B104 cells, independently of any known endogenous sealing mechanism. Third, Ca²âº-containing isotonic saline is applied to induce sealing of any remaining plasmalemmal holes by Ca²âº-induced accumulation and fusion of vesicles. These and other data suggest that PEG-sealing is neuroprotective, and our PEG-fusion protocols that repair cut- and crush-severed rat nerves might rapidly translate to clinical procedures.


Subject(s)
Behavior, Animal/drug effects , Methylene Blue/therapeutic use , Microsurgery/methods , Polyethylene Glycols/therapeutic use , Recovery of Function/physiology , Sciatic Neuropathy , Analysis of Variance , Animals , Disease Models, Animal , Electromyography , Evoked Potentials, Motor/drug effects , Fluorescent Dyes , Neural Conduction/drug effects , Neural Conduction/physiology , Rats , Rats, Sprague-Dawley , Recovery of Function/drug effects , Sciatic Neuropathy/drug therapy , Sciatic Neuropathy/physiopathology , Sciatic Neuropathy/surgery , Time Factors , Video Recording
SELECTION OF CITATIONS
SEARCH DETAIL
...